Open Access Maced J Med Sci. 2015 Jun 15;3(2):363-9. doi: 10.3889/oamjms.2015.032. Epub 2015 Mar 25.

Challenging Role of Dietary Aflatoxin B1 Exposure and Hepatitis B Infection on Risk of Hepatocellular Carcinoma.

Open access Macedonian journal of medical sciences

Basak Kucukcakan, Zehra Hayrulai-Musliu

PMID: 27275251 PMCID: PMC4877883 DOI: 10.3889/oamjms.2015.032

Abstract

Aflatoxins (AFT) are poisonous substances which are classified in Group 1 carcinogenic agents to humans by International Agency for Research on Cancer (IARC). AFT can occur naturally in food commodities (maize, corn, rice) as a result of fungal contamination in hot and humid environments. In the food, toxin contamination can remain during manufacturing and long after fungi have stopped being biologically active. Aflatoxin B1 (AFB1) is the most dominant and potent agent from all AFT. In developing countries, high exposure to AFB1 can cause chronic toxicity and usually increases the incidence of Hepatocellular Carcinoma (HCC). However, in these regions hepatitis B is the most common risk factor for HCC cases. Many researches were aimed to enlighten the mechanism and the role of two etiological agents on risk of HCC, but the obtained data was conflicting with each other. It was uncertain that the indicators/biomarkers might be the contribution of the carcinogenic status of the patient; and, the biomarker samples from the subject may only reflect the recent effects of the toxin exposure after consumption of AFB1 contaminated commodities. The studies were facing with the errors of methods which were un-fit to enlighten the possible interaction between Hepatitis B and AFB1 on contribution to HCC. It was pivotal to understand the effect of each risk factor in order to prevent and improve public health in poor and undeveloped regions. Although some of the studies evaluate AFB1 alone as a considerable factor on HCC risk, according to this review it was concluded vice versa. This study was aimed to clarify the main etiological agent of HCC where AFB1 and HBV are endangering public health. In additionally, the purpose was to enlighten the possible synergistic effect between these two factors among HCC pathogenesis. Hence forth, appropriate and right applications could be conducted in undeveloped countries in order to protect public health.

Keywords: Aflatoxin B1; Biomarker; Hepatitis B; Hepatocellular Carcinoma

References

1. J Hepatol. 2010 Oct;53(4):671-6 - PubMed
2. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):3-10 - PubMed
3. J Gen Virol. 2012 Mar;93(Pt 3):640-50 - PubMed
4. Cancer Res. 1992 Jan 1;52(1):45-52 - PubMed
5. Cancer Res. 1987 Jul 1;47(13):3430-3 - PubMed
6. Lancet. 1992 Apr 18;339(8799):943-6 - PubMed
7. Environ Health Perspect. 2010 Jun;118(6):818-24 - PubMed
8. Hepat Mon. 2012 Oct;12(10 HCC):e7238 - PubMed
9. Mutagenesis. 2002 Nov;17(6):471-81 - PubMed
10. World J Gastroenterol. 2013 Mar 14;19(10):1508-12 - PubMed
11. Cancer Res. 1990 Nov 1;50(21):6882-93 - PubMed
12. World J Hepatol. 2012 Mar 27;4(3):74-80 - PubMed
13. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):846-53 - PubMed
14. Oncogene. 2005 Sep 1;24(38):5858-67 - PubMed
15. Cancer Res. 1992 Feb 15;52(4):1044-6 - PubMed
16. Carcinogenesis. 1996 May;17(5):1007-12 - PubMed
17. Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):617-25 - PubMed
18. Environ Health Perspect. 1993 Mar;99:107-13 - PubMed
19. Clin Microbiol Rev. 2003 Jul;16(3):497-516 - PubMed
20. Int J Cancer. 1991 May 30;48(3):329-32 - PubMed
21. Ann Hepatol. 2008 Oct-Dec;7(4):339-44 - PubMed
22. Br J Cancer. 1973 Jun;27(6):473-84 - PubMed
23. Br J Cancer. 1985 May;51(5):713-26 - PubMed
24. J Gastrointestin Liver Dis. 2013 Sep;22(3):305-10 - PubMed
25. Trop Med Int Health. 2000 Dec;5(12):837-41 - PubMed
26. Environ Health Perspect. 2005 Dec;113(12):1779-83 - PubMed

Publication Types

• Journal Article
• Review